Neuralstem, Inc. (NASDAQ: CUR)
Neuralstem is having an incredibly strong day in the market today. When the opening bell rang, the stock was already trading slightly in the green. From there, it took a few minutes to really grab onto some momentum before rocketing toward the top. Below, we'll talk about what we're seeing from CUR, why, and what we'll be watching for ahead.
What We're Seeing From CUR
As mentioned above, Neuralstem is having an incredibly strong start to today's trading session. At the open, the stock was already trading slightly in the green. While it took a few minutes to get the momentum, the stock quickly rocketed to the top. At the moment (10:02), CUR is trading at $3.78 per share after a gain of $0.60 per share or 18.87% thus far today.
Why The Stock Is Making A Run For The Top
Our partners at Trade Ideas were the first to alert us of the gains on CUR, as is normally the case. As soon as the CNA Finance team got the alert, we started working to see what was causing the movement. In this particular case, there's some fundamental news going around that's really exciting investors.
Currently, Neuralstem is working on a Phase 2 clinical trial, from which data is expected to be released in the third fiscal quarter of 2017. Today however, the company announced the enrollment of its last patient. It is also expected that we will see the data from the clinical study ahead of schedule. Obviously, this is overwhelmingly positive news, which is leading to investor excitement.
What We'll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping an incredibly close eye on CUR. In particular, we'll be watching the company's progress through the ongoing Phase 2 clinical trial. Nonetheless, we'll watch the news closely and be sure to bring you any updates as they break!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!